Technology
Health
Pharmaceutical

Flex Pharma

$0.4099
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0069 (-1.66%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Flex Pharma and other stocks, options, ETFs, and crypto commission-free!

About

Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. Read More The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA.

Employees
4
Headquarters
Boston, Massachusetts
Founded
2014
Market Cap
7.53M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.15M
High Today
$0.4321
Low Today
$0.4027
Open Price
$0.4321
Volume
68.80K
52 Week High
$4.30
52 Week Low
$0.26

Collections

Technology
Health
Pharmaceutical
Medical
Biotechnology
2015 IPO
US
North America

News

Yahoo FinanceMay 1

Flex Pharma Reports First Quarter 2019 Financial Results

BOSTON--(BUSINESS WIRE)-- Flex Pharma, Inc. (FLKS), today announced its financial results for the three months ended March 31, 2019. On January 3, 2019, Flex Pharma (the "Company") and Salarius Pharmaceuticals, LLC ("Salarius") entered into an Agreement and Plan of Merger (the "Merger Agreement") pursuant to which, among other things, Falcon Acquisition Sub, LLC, a wholly owned subsidiary of the Company, will merge with and into Salarius, with Salarius continuing as a wholly owned subsidiary of the Compan...

1,168
Yahoo FinanceApr 26

FLKS ALERT: Monteverde & Associates PC Encourages Flex Pharma, Inc. Shareholders to Contact the Firm

1,331
Seeking AlphaApr 24

Flex Pharma files for $100M mixed shelf; shares down 13% after hours

Flex Pharma (NASDAQ:FLKS) has filed a prospectus for a $100M mixed shelf offering. Shares are off 13% after hours....

782

Earnings

-$0.58
-$0.42
-$0.27
-$0.11
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.